James Quigley
Stock Analyst at Goldman Sachs
(0.20)
# 4,422
Out of 4,581 analysts
332
Total ratings
39.8%
Success rate
-7.4%
Average return
Main Sectors:
Stocks Rated by James Quigley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Hold | €229.00 → €190.00 | €225.60 | -15.78% | 31 | Jul 24, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 670.00 → CHF 680.00 | CHF 574.80 | +18.30% | 22 | Jul 23, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Sell | CHF 111.00 → CHF 113.00 | CHF 129.74 | -12.90% | 27 | Jul 22, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €55.00 → €62.50 | €47.69 | +31.05% | 60 | Jul 6, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €89.00 → €84.00 | €79.92 | +5.11% | 10 | Jul 6, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 346.00 → CHF 348.00 | CHF 361.70 | -3.79% | 26 | Jun 30, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 263.00 → kr 305.00 | kr 335.80 | -9.17% | 35 | Jun 4, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | $41 → $47 | $51.58 | -8.88% | 9 | Jun 3, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €214.00 | €171.20 | +25.00% | 23 | Apr 23, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Buy | €153.00 → €147.00 | €145.10 | +1.31% | 43 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $54.97 | - | 1 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $121 → $118 | $158.83 | -25.71% | 3 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $897.50 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $60 | $44.85 | n/a | 2 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 15,200p | 12,978p | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €13.00 → €10.50 | €1.26 | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €27.00 → €28.00 | €3.47 | n/a | 10 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 65.00 → CHF 64.00 | CHF 73.60 | n/a | 2 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 38.00 → CHF 21.00 | CHF 43.85 | n/a | 5 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €38.00 → €36.00 | €24.54 | n/a | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $1.93 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €410.00 → €545.00 | €766.70 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | kr 1,950 → kr 2,235 | kr 1,892 | n/a | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $140 → $205 | $27.72 | n/a | 2 | Jan 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $28.52 | n/a | 1 | Jun 20, 2018 |
Sartorius Aktiengesellschaft
Jul 24, 2026
Maintained: Hold
Price Target: €229.00 → €190.00
Current: €225.60
Upside: -15.78%
Lonza Group AG
Jul 23, 2026
Maintained: Buy
Price Target: CHF 670.00 → CHF 680.00
Current: CHF 574.80
Upside: +18.30%
Novartis AG
Jul 22, 2026
Maintained: Sell
Price Target: CHF 111.00 → CHF 113.00
Current: CHF 129.74
Upside: -12.90%
Bayer Aktiengesellschaft
Jul 6, 2026
Maintained: Buy
Price Target: €55.00 → €62.50
Current: €47.69
Upside: +31.05%
Sanofi
Jul 6, 2026
Maintained: Hold
Price Target: €89.00 → €84.00
Current: €79.92
Upside: +5.11%
Roche Holding AG
Jun 30, 2026
Maintained: Hold
Price Target: CHF 346.00 → CHF 348.00
Current: CHF 361.70
Upside: -3.79%
Novo Nordisk A/S
Jun 4, 2026
Maintained: Hold
Price Target: kr 263.00 → kr 305.00
Current: kr 335.80
Upside: -9.17%
Novo Nordisk
Jun 3, 2026
Maintained: Hold
Price Target: $41 → $47
Current: $51.58
Upside: -8.88%
Sartorius Stedim Biotech S.A.
Apr 23, 2026
Maintained: Buy
Price Target: €214.00
Current: €171.20
Upside: +25.00%
Merck KGaA
Apr 16, 2026
Maintained: Buy
Price Target: €153.00 → €147.00
Current: €145.10
Upside: +1.31%
Jan 15, 2026
Upgraded: Hold
Price Target: n/a
Current: $54.97
Upside: -
Sep 12, 2025
Downgraded: Sell
Price Target: $121 → $118
Current: $158.83
Upside: -25.71%
Jul 30, 2025
Maintained: Hold
Price Target: n/a
Current: $897.50
Upside: n/a
Jul 3, 2025
Maintained: Hold
Price Target: $65 → $60
Current: $44.85
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: 15,200p
Current: 12,978p
Upside: n/a
Oct 10, 2023
Maintained: Hold
Price Target: €13.00 → €10.50
Current: €1.26
Upside: n/a
Sep 25, 2023
Maintained: Buy
Price Target: €27.00 → €28.00
Current: €3.47
Upside: n/a
Sep 25, 2023
Maintained: Sell
Price Target: CHF 65.00 → CHF 64.00
Current: CHF 73.60
Upside: n/a
Sep 25, 2023
Maintained: Hold
Price Target: CHF 38.00 → CHF 21.00
Current: CHF 43.85
Upside: n/a
Sep 5, 2023
Maintained: Hold
Price Target: €38.00 → €36.00
Current: €24.54
Upside: n/a
Aug 8, 2023
Maintained: Buy
Price Target: $16 → $15
Current: $1.93
Upside: n/a
Jul 28, 2023
Maintained: Buy
Price Target: €410.00 → €545.00
Current: €766.70
Upside: n/a
May 12, 2023
Initiated Coverage: Sell
Price Target: kr 1,950 → kr 2,235
Current: kr 1,892
Upside: n/a
Jan 5, 2020
Downgraded: Hold
Price Target: $140 → $205
Current: $27.72
Upside: n/a
Jun 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $28.52
Upside: n/a